Leadership

At Paracrine Therapeutics, we’ve brought together a seasoned and diverse team, encompassing a wide range of skills and knowledge across the entire spectrum of drug development, from initial research to intellectual property management and the introduction of innovative drug modalities to the market. Our commitment lies in establishing an open and transparent workplace that encourages collaboration and innovation. With an unwavering dedication to our mission, we aim to enhance the quality of life for patients grappling with severe diseases.

CHIEF EXECUTIVE OFFICER
CHIEF OPERATING OFFICER
Company Secretary

FCA Singapore, FCCA, Accredited Tax Advisor

Consultant
First to discover MSC exosome Clarivate Highly Cited Researcher 2021-2023
Consultant

Extensive track record in commercialization of early-stage biotechnologies.

Consultant

Extensive track record in biologics manufacturing (FDA and EMA)

Shopping Cart
Scroll to Top

Tan Thong Teck

CHIEF EXECUTIVE OFFICER

-Stem Cell and exosome expert
-BSc (Hons), University of Queensland (2005)
-PhD, National University of Singapore (2015)

 

Tan Soon Sim

CHIEF OPERATING OFFICER

Steven Luk

Company Secretary

– FCA Singapore, FCCA, Accredited Tax Advisor

Lai Ruenn Chai

PhD
Consultant

– A*STAR IMCB Research Scientist

– First to identify MSC exosome

– World’s Top 0.1% of researchers (Clarivate Highly Cited Researchers)

 

Scott Wheelwright

PhD
Consultant

– Extensive track record in biologics manufacturing (FDA and EMA)

 

Wong Ju Wei

PhD
Consultant

– Bio-manufacturing consultant with extensive proven experience in commercialization of early-stage biotechnologies.